Skip to main content

Northwestern Startup: Akava Therapeutics

For licensing information, contact:
Startup Available for Partnership,
logo

Founded: 2019

Northwestern Inventor:

Richard Silverman

Weinberg College of Arts and Sciences
Department of Chemistry and Department of Molecular Biosciences
Feinberg School of Medicine
Department of Pharmacology

AKAVA Therapeutics is developing first-in-class small molecule therapeutics that inhibit enzymes, inhibit cancer, and inhibit protein aggregation for a variety of cancers and neurodegenerative diseases.

AKAVA Therapeutics Website

Patent Information:
Categories:

Life Sciences > Therapeutics

Keywords:

ALS - Amyotrophic Lateral Sclerosis
Neurodegenerative disease
Neurology
Therapeutics